0001855763-24-000002.txt : 20240315
0001855763-24-000002.hdr.sgml : 20240315
20240315162243
ACCESSION NUMBER: 0001855763-24-000002
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240314
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cabatuan Nelson
CENTRAL INDEX KEY: 0001725908
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39874
FILM NUMBER: 24755129
MAIL ADDRESS:
STREET 1: RIGEL PHARMACEUTICALS, INC.
STREET 2: 1180 VETERANS BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexaria Bioscience Corp.
CENTRAL INDEX KEY: 0001348362
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 202000871
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0831
BUSINESS ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
BUSINESS PHONE: 250-765-6424
MAIL ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
FORMER COMPANY:
FORMER CONFORMED NAME: LEXARIA CORP.
DATE OF NAME CHANGE: 20080229
FORMER COMPANY:
FORMER CONFORMED NAME: Lexaria Corp.
DATE OF NAME CHANGE: 20051229
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2024-03-14
0
0001348362
Lexaria Bioscience Corp.
LEXX
0001725908
Cabatuan Nelson
LEXARIA BIOSCIENCE CORP.
100 - 740 MCCURDY ROAD
KELOWNA
A1
V1X 2P7
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Financial Officer
Stock Options
2.93
2024-03-15
2029-03-15
Common Shares
200000
D
50,000 options are exercisable on March 15, 2024, an additional 50,000 options are exercisable on March 15, 2025, thereafter an additional 4,166 options are exercisable monthly until Feb. 15, 2027 with the balance of 4,182 options being exercisable on March 15, 2027
/Nelson Cabatuan/
2024-03-15